Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.
Janota O, Mantovani M, Kwiendacz H, Irlik K, Bucci T, Lam SHM, Huang B, Alam U, Boriani G, Hendel M, Piaśnik J, Olejarz A, Włosowicz A, Pabis P, Wójcik W, Gumprecht J, Lip GYH, Nabrdalik K. Janota O, et al. Among authors: alam u. Cardiovasc Diabetol. 2024 Sep 3;23(1):326. doi: 10.1186/s12933-024-02420-x. Cardiovasc Diabetol. 2024. PMID: 39227929 Free PMC article.
All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes.
Riley DR, Essa H, Austin P, Preston F, Kargbo I, Ibarburu GH, Ghuman R, Cuthbertson DJ, Lip GYH, Alam U. Riley DR, et al. Among authors: alam u. Diabetes Obes Metab. 2023 Oct;25(10):2897-2909. doi: 10.1111/dom.15185. Epub 2023 Jun 29. Diabetes Obes Metab. 2023. PMID: 37385958
Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated database.
Anson M, Henney AE, Zhao SS, Ibarburu GH, Lip GYH, Cuthbertson DJ, Nabrdalik K, Alam U. Anson M, et al. Among authors: alam u. Diabetes Obes Metab. 2024 Jul;26(7):2606-2623. doi: 10.1111/dom.15576. Epub 2024 Apr 1. Diabetes Obes Metab. 2024. PMID: 38558280
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
Eleftheriadou A, Riley D, Zhao SS, Austin P, Hernández G, Lip GYH, Jackson TL, Wilding JPH, Alam U. Eleftheriadou A, et al. Among authors: alam u. Diabetologia. 2024 Jul;67(7):1271-1282. doi: 10.1007/s00125-024-06132-5. Epub 2024 Apr 8. Diabetologia. 2024. PMID: 38584180 Free PMC article.
Artificial intelligence-enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes.
Irlik K, Aldosari H, Hendel M, Kwiendacz H, Piaśnik J, Kulpa J, Ignacy P, Boczek S, Herba M, Kegler K, Coenen F, Gumprecht J, Zheng Y, Lip GYH, Alam U, Nabrdalik K. Irlik K, et al. Among authors: alam u. Diabetes Obes Metab. 2024 Jul;26(7):2624-2633. doi: 10.1111/dom.15578. Epub 2024 Apr 11. Diabetes Obes Metab. 2024. PMID: 38603589
231 results